Filed: 2/14/2024ACC: 0001591986-24-000002
📋 What this filing means
AQUILO CAPITAL MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 10 equity positions with a total reported market value of $160.45M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
10
Positions
$160.45M
Total AUM (reported)
5.99M
Total Shares
Allocation by class
COM$124.47M77.6%
ADS$18.12M11.3%
UNIT$17.86M11.1%
Portfolio Concentration
Top 3$73.74M46.0%
4–10$86.71M54.0%
Top 3 weight
46.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 5.99M
Sole
Full voting authority
5.79M
shares
% of voting shares96.7%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
200K
shares
% of voting shares3.3%
Investment Discretion (by position count)
Sole10
Shared0
Other0
Dominant voting typeSole · 96.7% of voting shares
Institutional Holdings10
Rows:
ARROWHEAD PHARMACEUTICALS IN
SOLEShares908.47K
TypeSH
Market value$27.80M
17.33%
Sole
908.47K
Shared
0.00
None
0.00
BLUEPRINT MEDICINES CORP
SOLEShares254.83K
TypeSH
Market value$23.51M
14.65%
Sole
254.83K
Shared
0.00
None
0.00
KYMERA THERAPEUTICS INC
SOLEShares881.34K
TypeSH
Market value$22.44M
13.98%
Sole
881.34K
Shared
0.00
None
0.00
ARVINAS INC
SOLEShares489.15K
TypeSH
Market value$20.13M
12.55%
Sole
489.15K
Shared
0.00
None
0.00
SILENCE THERAPEUTICS PLC
SOLEShares1.04M
TypeSH
Market value$18.12M
11.29%
Sole
1.04M
Shared
0.00
None
0.00
S&P BIOTECH ETF TR
SOLEShares200K
TypeSH
Market value$17.86M
11.13%
Sole
0.00
Shared
0.00
None
200K
REGENXBIO INC
SOLEShares802.42K
TypeSH
Market value$14.40M
8.98%
Sole
802.42K
Shared
0.00
None
0.00
MERUS N V
SOLEShares355.11K
TypeSH
Market value$9.77M
6.09%
Sole
355.11K
Shared
0.00
None
0.00
REPARE THERAPEUTICS INC
SOLEShares633.27K
TypeSH
Market value$4.62M
2.88%
Sole
633.27K
Shared
0.00
None
0.00
SUTRO BIOPHARMA INC
SOLEShares420.65K
TypeSH
Market value$1.80M
1.12%
Sole
420.65K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ARROWHEAD PHARMACEUTICALS INSOLE | COM | 908.47K | SH | $27.80M 17.33% | 908.47K | 0.00 | 0.00 |
BLUEPRINT MEDICINES CORPSOLE | COM | 254.83K | SH | $23.51M 14.65% | 254.83K | 0.00 | 0.00 |
KYMERA THERAPEUTICS INCSOLE | COM | 881.34K | SH | $22.44M 13.98% | 881.34K | 0.00 | 0.00 |
ARVINAS INCSOLE | COM | 489.15K | SH | $20.13M 12.55% | 489.15K | 0.00 | 0.00 |
SILENCE THERAPEUTICS PLCSOLE | ADS | 1.04M | SH | $18.12M 11.29% | 1.04M | 0.00 | 0.00 |
S&P BIOTECH ETF TRSOLE | UNIT | 200K | SH | $17.86M 11.13% | 0.00 | 0.00 | 200K |
REGENXBIO INCSOLE | COM | 802.42K | SH | $14.40M 8.98% | 802.42K | 0.00 | 0.00 |
MERUS N VSOLE | COM | 355.11K | SH | $9.77M 6.09% | 355.11K | 0.00 | 0.00 |
REPARE THERAPEUTICS INCSOLE | COM | 633.27K | SH | $4.62M 2.88% | 633.27K | 0.00 | 0.00 |
SUTRO BIOPHARMA INCSOLE | COM | 420.65K | SH | $1.80M 1.12% | 420.65K | 0.00 | 0.00 |